ZEGA Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$120K Sell
100
-1,600
-94% -$1.63M 0.01% 315
2026
Q1
$1.56M Buy
+1,700
New +$1.72M 0.18% 67

Other funds holding LLY

ZEGA Investments's LLY Position: Q2 2026 in Review

ZEGA Investments reduced its Eli Lilly (LLY) stake by 15% in Q2 2026, selling an estimated $1.19M and leaving 6,635 shares worth $7.96M. The position accounts for 0.82% of the portfolio, ranked #23.

ZEGA Investments first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.23M in Q4 2025. 2,170 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ZEGA Investments held 6,635 shares of Eli Lilly worth $7.96M as of Q2 2026.
  • ZEGA Investments sold 1,168 Eli Lilly shares in Q2 2026, an estimated $1.19M.
  • Eli Lilly made up 0.82% of ZEGA Investments's portfolio in Q2 2026, its #23 holding.
  • ZEGA Investments first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • ZEGA Investments's Eli Lilly position peaked at $8.23M in Q4 2025.
  • 2,170 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ZEGA Investments's 13F filing for Q2 2026, filed 31 Jul 2026.